MRK
Merck & Company Inc
148.10$
-1.9%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 29.9% | 30.2% | 29.7% | 33.9% | 34.3% | 33.1% | 30.8% | 31.5% | 36.7% | 31.8% | 27.2% | 28.3% | |
| 8.1% | 6.4% | 5.3% | 10.0% | 12.4% | 11.3% | 7.5% | 6.8% | 14.0% | 10.6% | 4.1% | 5.3% | |
| 8.2% | 6.6% | – | 10.1% | 12.4% | 11.7% | 8.0% | 7.3% | 14.1% | 10.6% | 4.4% | 5.5% | |
| 9.7% | 9.7% | 10.7% | 10.3% | 9.7% | 8.8% | 9.4% | 10.1% | 9.4% | 9.3% | 9.5% | 9.7% | |
| 5.7% | 6.0% | 6.2% | 5.7% | 5.3% | 5.2% | 5.4% | 5.6% | 5.0% | 4.9% | 5.0% | 4.8% | |
| 21.1% | – | – | – | 19.9% | 20.3% | 21.5% | 21.5% | 19.8% | 18.5% | – | – | |
| 19.8% | 19.9% | 20.0% | 18.8% | 18.5% | 18.5% | 18.8% | 18.4% | 16.7% | 15.8% | 16.8% | 16.6% | |
| 18.0% | 16.9% | 16.6% | 15.1% | 14.5% | 14.0% | 13.7% | 12.9% | 11.8% | 19.5% | 20.0% | 19.2% | |
| 61.3% | 64.7% | 61.8% | 61.2% | 62.1% | 60.4% | 58.0% | 58.3% | 59.9% | 61.5% | 64.3% | 67.7% | |
| 21.6% | 24.1% | 23.7% | 23.1% | 25.2% | 24.3% | 21.9% | 22.2% | 22.1% | 20.7% | 20.9% | 21.4% | |
| 0.8% | 1.6% | – | 2.7% | 2.7% | 2.5% | 1.2% | 1.2% | 1.1% | 2.1% | 1.9% | 2.2% | |
| 3.3% | 3.7% | 3.3% | 3.1% | 3.1% | 3.5% | 3.3% | 3.3% | 3.2% | 3.2% | 3.0% | 2.9% | |
| 31.8% | 31.6% | 29.4% | 30.8% | 29.8% | 29.4% | 29.1% | 28.9% | 30.9% | 34.2% | 36.3% | 39.4% | |
| 38.6% | 35.2% | 38.1% | 38.7% | 37.9% | 39.5% | 42.0% | 41.7% | 40.0% | 38.4% | 35.7% | 32.3% | |
| 53.5% | 50.5% | 53.6% | 53.4% | 52.2% | 53.9% | 57.4% | 58.3% | 55.8% | 53.4% | 51.8% | 48.7% | |
| 2.4% | 2.4% | 2.4% | 2.3% | 2.2% | 2.2% | 2.2% | 2.1% | 1.9% | 1.8% | 1.9% | 1.9% |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.